217 related articles for article (PubMed ID: 21308296)
1. Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: a histometric study in rats.
Fracon RN; Teófilo JM; Moris IC; Lamano T
J Appl Oral Sci; 2010 Dec; 18(6):630-4. PubMed ID: 21308296
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
[TBL] [Abstract][Full Text] [Related]
3. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis.
Setia S; Sanyal SN
Pharmacol Rep; 2012; 64(3):615-24. PubMed ID: 22814015
[TBL] [Abstract][Full Text] [Related]
5. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
[TBL] [Abstract][Full Text] [Related]
6. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory and analgesic actions of etoricoxib (an NSAID) combined with misoprostol.
Moraes BM; do Amaral BC; Morimoto MS; Vieira LG; Perazzo FF; Carvalho JC
Inflammopharmacology; 2007 Aug; 15(4):175-8. PubMed ID: 17701021
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
Vuolteenaho K; Moilanen T; Moilanen E
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing.
O'Connor JP; Capo JT; Tan V; Cottrell JA; Manigrasso MB; Bontempo N; Parsons JR
Acta Orthop; 2009 Oct; 80(5):597-605. PubMed ID: 19916696
[TBL] [Abstract][Full Text] [Related]
10. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B
Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.
Corzo JL; Zambonino MA; Muñoz C; Mayorga C; Requena G; Urda A; Gallego C; Blanca M; Torres MJ
Br J Dermatol; 2014 Mar; 170(3):725-9. PubMed ID: 24116718
[TBL] [Abstract][Full Text] [Related]
12. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.
Graham GG; Davies MJ; Day RO; Mohamudally A; Scott KF
Inflammopharmacology; 2013 Jun; 21(3):201-32. PubMed ID: 23719833
[TBL] [Abstract][Full Text] [Related]
13. Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy.
Moro MG; Sanchez PK; Gevert MV; Baller EM; Tostes AF; Lupepsa AC; Baglie S; Franco GC
Braz Oral Res; 2016 Nov; 30(1):e127. PubMed ID: 27901208
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment.
Katyal J; Kumar H; Gupta YK
Epilepsy Behav; 2015 Mar; 44():98-103. PubMed ID: 25660085
[TBL] [Abstract][Full Text] [Related]
15. Mucosal exfoliation as a selective reaction to etoricoxib.
Patanè M; Isola S; Gangemi S; Minciullo PL
J Clin Pharm Ther; 2016 Dec; 41(6):722-724. PubMed ID: 27576781
[TBL] [Abstract][Full Text] [Related]
16. [Effect of nonsteroidal anti-inflammatory drugs on the indicators of cardiovascular risk in patients with acute nonspecific back pain].
Zolotovskaya IA; Davydkin IL
Ter Arkh; 2015; 87(12):18-25. PubMed ID: 26978413
[TBL] [Abstract][Full Text] [Related]
17. Etoricoxib.
Cochrane DJ; Jarvis B; Keating GM
Drugs; 2002; 62(18):2637-51; discussion 2652-3. PubMed ID: 12466002
[TBL] [Abstract][Full Text] [Related]
18. Safety of etoricoxib in patients with reactions to NSAIDs.
Quercia O; Emiliani F; Foschi FG; Stefanini GF
J Investig Allergol Clin Immunol; 2008; 18(3):163-7. PubMed ID: 18564626
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats.
Citraro R; Leo A; Marra R; De Sarro G; Russo E
Brain Res Bull; 2015 Apr; 113():1-7. PubMed ID: 25701797
[TBL] [Abstract][Full Text] [Related]
20. Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.
Watson DJ; Bolognese JA; Yu C; Krupa D; Curtis S
Curr Med Res Opin; 2004 Dec; 20(12):1899-908. PubMed ID: 15701208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
